Close Menu

NEW YORK (GenomeWeb) — Thermo Fisher Scientific announced today that it has received CE-IVD marking for its Oncomine Dx Target Test.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.